Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bank of America

46.03
-0.1200-0.26%
Post-market: 45.99-0.0400-0.09%19:59 EDT
Volume:61.30M
Turnover:2.81B
Market Cap:346.69B
PE:13.74
High:46.56
Open:46.25
Low:45.01
Close:46.15
Loading ...

U.S. Banking Titans Reap Gains from Q2 Trading Activity Resurgence

Market Watcher
·
15 Jul

Bank Stocks Fall After JPMorgan, Wells Fargo, and Citi Earnings — Citi Bucks the Trend

Tiger Newspress
·
15 Jul

Bank of America Corp - Credit Card Delinquency Rate Was 1.38% at June End - SEC Filing

THOMSON REUTERS
·
15 Jul

Urbana Corporation Reports Estimated Net Asset Value of $11.66 Per Share as of July 11, 2025, Driven by Strong Portfolio Performance

Reuters
·
15 Jul

Howmet Aerospace (HWM) Gets a Buy from Bank of America Securities

TIPRANKS
·
15 Jul

Bank of America Securities Remains a Buy on Caci International (CACI)

TIPRANKS
·
15 Jul

Bank of America Securities Sticks to Their Buy Rating for Progressive (PGR)

TIPRANKS
·
15 Jul

Block (XYZ): New Buy Recommendation for This Technology Giant

TIPRANKS
·
15 Jul

Churchill Downs (CHDN) Receives a Buy from Bank of America Securities

TIPRANKS
·
15 Jul

Bank of America Securities Sticks to Their Buy Rating for Boyd Gaming (BYD)

TIPRANKS
·
15 Jul

Alphabet Class A (GOOGL) Gets a Buy from Bank of America Securities

TIPRANKS
·
15 Jul

WRAPUP 1-US banking giants reap gains from dealmaking rebound

Reuters
·
15 Jul

Fund manager cash levels drop, triggering sell signal in latest Bank of America survey

Dow Jones
·
15 Jul

Have a Bank of America Savings Account? You're Probably Missing Out on $300-Plus a Year

Motley Fool
·
15 Jul

Chewy’s Growth Potential in Vet Care and Pharmacy Drives Buy Rating

TIPRANKS
·
15 Jul

Buy Rating Affirmed for Rhythm Pharmaceuticals on Promising Data and Market Expansion Potential

TIPRANKS
·
15 Jul

OPENLANE (KAR) Gets a Hold from Bank of America Securities

TIPRANKS
·
15 Jul

Kenvue, Inc. Buy Rating Reiterated Amid CEO Transition and Strategic Review

TIPRANKS
·
15 Jul

Avidity Biosciences Positioned for Leadership in Muscular Dystrophy with Strategic Regulatory Advancements

TIPRANKS
·
15 Jul

Neurocrine’s Growth Potential Driven by Ingrezza’s Market Share and Crenessity’s Uptake

TIPRANKS
·
15 Jul